A world leader in nuclear medicine


ANSTO is central to Australia’s nuclear medicine manufacturing capabilities. Each week ANSTO delivers 10,000 patient doses of potentially lifesaving nuclear medicines to over 250 hospitals and medical practices across Australia. 



 

Nuclear medicines are used to diagnose a wide range of illnesses including cardiac conditions, cancers and skeletal injuries. It is estimated one in two Australians will benefit from the nuclear medicines that originate from ANSTO.
 

A new project currently in development at ANSTO will position Australia as a global leader in the high-end manufacturing of nuclear medicine. The ANSTO Nuclear Medicine Project (ANM) is a manufacturing plant that will be located in the heart of the Sutherland Shire in Sydney. Around 80 per cent of all nuclear medicine procedures conducted worldwide use technetium-99m.

With the ANM project  Australia will triple its production of this vital medicine used in research and diagnosis for the benefit of not only Australians, but the rest of the world. 
 
The ANM Project includes a nuclear medicine manufacturing plant and a Synroc waste treatment plant and will be operational late in 2016.